BioInfra Life Science Inc. (XKON:266470)
South Korea flag South Korea · Delayed Price · Currency is KRW
215.00
+15.00 (7.50%)
At close: Feb 13, 2026

BioInfra Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2019FY 2018FY 2017FY 2016
Period Ending
Feb '26 Dec '19 Dec '18 Dec '17 Dec '16
Debt / Equity Ratio
-8.67-91.120.150.140.06
Net Debt / Equity Ratio
-2.46-16.08-0.22-0.43-0.51
Net Debt / EBITDA Ratio
-0.93-0.610.200.681.35
Net Debt / FCF Ratio
-1.00-0.610.160.551.22
Asset Turnover
0.230.210.260.16-
Quick Ratio
1.661.873.723.3020.98
Current Ratio
1.671.873.874.1023.67
Return on Equity (ROE)
-746.62%-230.95%-100.74%-58.82%-
Return on Assets (ROA)
-28.10%-23.72%-37.93%-23.33%-
Return on Capital Employed (ROCE)
-57.90%-47.10%-79.00%-56.90%-35.90%
Buyback Yield / Dilution
2.59%1.87%-6.28%-1.42%-
Updated May 19, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.